Church of PeptidesSearch
Portrait of MOTS-c
Pilgrims · 2015

MOTS-c

The Mitochondrial Scout

Los Angeles, USA

MOTS-c is a peptide encoded within mitochondrial DNA and studied as a metabolic signal. Research connects it with cellular stress responses and insulin sensitivity, but measuring naturally occurring MOTS-c is different from proving that administering it benefits people.

Evidence ladder: Observational evidenceEvidence ladder: In-vitro mechanismEducational record
ClassificationPilgrims
Evidence summaryHuman associations · treatment benefit unestablished
OriginLos Angeles, USA
Scientific record

What the evidence says

Established role or proposed benefit

  • Participates in experimental metabolic and stress-response biology.
  • Early human research has explored exercise and metabolic questions.

Side effects, risks, and limits

  • No approved therapeutic use.
  • Human efficacy, long-term safety, and meaningful clinical outcomes remain uncertain.
Doctide’s verdict

The Mitochondrial Scout delivered an interesting biological message. Doctide has not yet received the clinical trial results needed to turn that message into a reliable metabolic or longevity treatment.

Documented history

Where the real story begins

Lee and colleagues described MOTS-c in 2015, identifying a short sequence within mitochondrial DNA and examining its activity in cells and mice. Their experiments helped broaden the view of mitochondria from energy-producing structures to sources of signals affecting metabolism. Historical source.

Los Angeles, USA · 2015
Book of the Canon · comic scripture

The laboratory legend

MOTS-c emerged from inside the mitochondrial library carrying a tiny message about cellular stress. Doctide checked twice because the messenger came from an unexpected book.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. Cell and animal experiments differ from human treatment trials. The human association study below does not test injected MOTS-c as a treatment.

  1. Original cell and mouse research, 2015
  2. Observational study of circulating MOTS-c and insulin sensitivity, 2018
  3. FDA MOTS-c safety information

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.